| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 13.689 | 16.553 | 15.061 | 23.237 | 19.637 | 23.863 | 45.824 |
| Total Income - EUR | - | - | - | 13.689 | 16.553 | 15.061 | 23.237 | 19.637 | 23.863 | 45.824 |
| Total Expenses - EUR | - | - | - | 3.270 | 5.537 | 6.011 | 12.251 | 12.766 | 15.630 | 30.981 |
| Gross Profit/Loss - EUR | - | - | - | 10.418 | 11.016 | 9.049 | 10.987 | 6.871 | 8.233 | 14.842 |
| Net Profit/Loss - EUR | - | - | - | 10.008 | 10.519 | 8.633 | 10.351 | 6.404 | 8.023 | 13.495 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dr Vlad Dobosan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.591 | 10.431 | 17.957 | 13.745 | 10.479 | 62.782 |
| Current Assets | - | - | - | 10.357 | 9.649 | 8.991 | 11.600 | 16.962 | 8.825 | 14.181 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 1.482 | 1.478 | 0 |
| Receivables | - | - | - | 1.805 | 927 | 724 | 1.253 | 7.868 | 1.474 | 5.233 |
| Cash | - | - | - | 8.551 | 8.722 | 8.268 | 10.347 | 7.612 | 5.874 | 8.949 |
| Shareholders Funds | - | - | - | 10.222 | 10.772 | 19.201 | 23.274 | 6.647 | 10.607 | 24.042 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 134 | 468 | 221 | 6.284 | 24.060 | 8.698 | 52.921 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Vlad Dobosan S.r.l.